Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced four preclinical poster presentations at ...

The posters are all part of the conference poster session, will be judged by experts, and will be eligible for one of several conference awards and incentives (details shared separately). In addition, ...

We designed the Poster Session with the idea of offering an informal place ... first poster at your “home field”, which will make presenting one at your first conference less time consuming, less ...

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced two upcoming ...